| Description | CPSA is an effective and selective AKR1C1 inhibitor. |
| molecular weight | 248.66 |
| Molecular formula | C13H9ClO3 |
| CAS | 1038713-54-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Siegel SD, Liu J, Ton-That H. Biogenesis of the Gram-positive bacterial cell envelope. Curr Opin Microbiol. 2016 Dec;34:31-37. doi: 10.1016/j.mib.2016.07.015. Epub 2016 Aug 4. Review. PubMed PMID: 27497053; PubMed Central PMCID: PMC5164837. 2. Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N. Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer. J Urol. 2013 Aug;190(2):389-98. doi: 10.1016/j.juro.2013.02.005. Epub 2013 Mar 29. Review. PubMed PMID: 23545099. 3. Shan L. (125)I-Labeled monoclonal antibody PSA30. 2012 Nov 9 [updated 2012 Dec 5]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK114649/ PubMed PMID: 23236644. 4. Benchikh El Fegoun A, Villers A. [Molecular forms of PSA]. Prog Urol. 2007 Apr;17(2):165-71. Review. French. PubMed PMID: 17489311. |